NHS Tayside Sign Up to Early Warning System Miya Observations

Alcidion LtdNHS Tayside has signed a five-year agreement with smart health tech provider Alcidion to deploy Miya Observations, an electronic monitoring system that will help thousands of busy healthcare professionals as they care for patients.

Formerly known as Patientrack, the system has already delivered substantial clinical benefits in other NHS hospitals, including early adopters in Scotland, where alerts provided by the system and improved visibility of the sickest patients, have helped staff to significantly enhance patient safety and cut cardiac arrests.

NHS Tayside, which employs 14,000 people and serves a population of more than 400,000 across rural and urban communities in Dundee City, Angus and Perth and Kinross, will deploy Miya Observations throughout its regional network.

Miya Observations provides an early warning system that shares critical information as soon as it is recorded, rather than simply passively capturing a patient’s vital signs on a paper-based bedside chart. The system alerts clinical staff when patients show signs of deterioration, so healthcare professionals can rapidly intervene and focus on those patients immediately in need. It has helped hospitals to prevent negative clinical outcomes and to manage risks around deadly conditions including acute kidney injury and sepsis. Hospitals using the system have observed reduced length of stay and many other benefits.

NHS Tayside will use Miya Observations across approximately 975 beds to electronically record vital signs and patient observations, produce charts, automatically calculate patient early warning scores, generate clinical alerts, and document a range of clinical assessments.

Alcidion UK Commercial Director Tom Scott said: "We are thrilled to be partnering with NHS Tayside, extending Miya Observations to a third health board in Scotland. This agreement represents recognition of the benefits that are realised through capturing key clinical data at the bedside, and reporting and acting on it in real time."

Alcidion Group Managing Director Kate Quirke said: "Healthcare technology should exist to deliver benefits to the people delivering and receiving care. It should help to make the right thing to do the easiest thing to do. I look forward to seeing these benefits extend to healthcare professionals and patients in NHS Tayside as the health board deploys Alcidion’s Miya capabilities. It is rewarding to see this success story continue to grow in Scotland, and to be welcoming another important NHS customer in the UK."

About NHS Tayside

Tayside Health Board was established in April 1974 and is responsible for commissioning health care services for the residents in the geographical local government areas of Angus, Dundee and Perth and Kinross.

The Board's boundaries are coterminous with these local government areas, which had a combined population of 416,090 based on mid-year 2017 population estimates published by National Records of Scotland.

NHS Tayside's governance includes three major and a number of community hospitals, including the University of Dundee's Medical School attached to the regions flagship institute, Ninewells Hospital in Dundee. It also includes over 60 GP surgeries and a variety of health centres staffed by thousands of employees of the health region.

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...